Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Operating Income (2016 - 2025)

Standard Biotools (LAB) has disclosed Operating Income for 16 consecutive years, with -$24.6 million as the latest value for Q4 2025.

  • Quarterly Operating Income fell 129.9% to -$24.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$116.2 million through Dec 2025, down 234.8% year-over-year, with the annual reading at -$110.2 million for FY2025, 480.78% down from the prior year.
  • Operating Income for Q4 2025 was -$24.6 million at Standard Biotools, up from -$32.9 million in the prior quarter.
  • The five-year high for Operating Income was $82.4 million in Q4 2024, with the low at -$60.2 million in Q1 2024.
  • Average Operating Income over 5 years is -$17.8 million, with a median of -$24.6 million recorded in 2025.
  • The sharpest move saw Operating Income surged 287.72% in 2023, then crashed 262.7% in 2024.
  • Over 5 years, Operating Income stood at -$19.6 million in 2021, then decreased by 7.65% to -$21.1 million in 2022, then soared by 287.72% to $39.6 million in 2023, then soared by 107.97% to $82.4 million in 2024, then plummeted by 129.9% to -$24.6 million in 2025.
  • According to Business Quant data, Operating Income over the past three periods came in at -$24.6 million, -$32.9 million, and -$25.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.